Leonard JP - Search Results

1

Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase I/II results.

Morschhauser F, Leonard JP, Fayad L, Coiffier B, Petillon MO, Coleman M, Schuster SJ, Dyer MJ, Horne H, Teoh N, Wegener WA, Goldenberg DM. Morschhauser F, et al. Among authors: leonard jp. J Clin Oncol. 2009 Jul 10;27(20):3346-53. doi: 10.1200/JCO.2008.19.9117. Epub 2009 May 18. J Clin Oncol. 2009. PMID: 19451441 Clinical Trial.

2

Primary non-Hodgkin's lymphoma of bone.

Leonard JP, Coleman M. Leonard JP, et al. Cancer Invest. 1998;16(8):616-7. doi: 10.3109/07357909809032893. Cancer Invest. 1998. PMID: 9844623 No abstract available.

3

Treatment of nonlaparotomized (clinical) stage I and II Hodgkin's disease patients by extended field and splenic irradiation.

Coleman M, Kaufmann T, Nisce LZ, Leonard JP. Coleman M, et al. Among authors: leonard jp. Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1235-8. doi: 10.1016/s0360-3016(99)00511-8. Int J Radiat Oncol Biol Phys. 2000. PMID: 10725636

4

DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL).

Coleman M, Leonard J, Shuster MW, Kaufman TP. Coleman M, et al. Eur J Haematol Suppl. 2001 Jul;64:41-5. Eur J Haematol Suppl. 2001. PMID: 11486401 Clinical Trial.

5

Biology and management of mantle cell lymphoma.

Leonard JP, Schattner EJ, Coleman M. Leonard JP, et al. Curr Opin Oncol. 2001 Sep;13(5):342-7. doi: 10.1097/00001622-200109000-00005. Curr Opin Oncol. 2001. PMID: 11555710 Review.

6

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.

Kaminski MS, Zelenetz AD, Press OW, Saleh M, Leonard J, Fehrenbacher L, Lister TA, Stagg RJ, Tidmarsh GF, Kroll S, Wahl RL, Knox SJ, Vose JM. Kaminski MS, et al. J Clin Oncol. 2001 Oct 1;19(19):3918-28. doi: 10.1200/JCO.2001.19.19.3918. J Clin Oncol. 2001. PMID: 11579112 Clinical Trial.

7

Immunotherapy of Non-Hodgkin's lymphomas.

Press OW, Leonard JP, Coiffier B, Levy R, Timmerman J. Press OW, et al. Among authors: leonard jp. Hematology Am Soc Hematol Educ Program. 2001:221-40. doi: 10.1182/asheducation-2001.1.221. Hematology Am Soc Hematol Educ Program. 2001. PMID: 11722986 Review.

8

Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.

Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ. Kostakoglu L, et al. Among authors: leonard jp. Cancer. 2002 Feb 15;94(4):879-88. Cancer. 2002. PMID: 11920454 Free article. Clinical Trial.

9

PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

Kostakoglu L, Coleman M, Leonard JP, Kuji I, Zoe H, Goldsmith SJ. Kostakoglu L, et al. Among authors: leonard jp. J Nucl Med. 2002 Aug;43(8):1018-27. J Nucl Med. 2002. PMID: 12163626 Free article.

10

Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone.

Coleman M, Leonard J, Lyons L, Szelenyi H, Niesvizky R. Coleman M, et al. Semin Oncol. 2003 Apr;30(2):270-4. doi: 10.1053/sonc.2003.50044. Semin Oncol. 2003. PMID: 12720151 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters